Intech Biopharm Ltd (6461) — Financial Flexibility Index
Intech Biopharm Ltd (6461) has a Financial Flexibility Index of -0.06x as of March 2026. Free cash flow of NT$-75.16 Million (operating CF NT$-84.50 Million minus capex NT$9.33 Million) represents 0% of total liabilities (NT$1.34 Billion). Check Intech Biopharm Ltd (6461) tangible net worth to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Intech Biopharm Ltd Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Intech Biopharm Ltd across 9 annual periods. For the full cash flow conversion analysis, see Intech Biopharm Ltd cash flow conversion.
Annual Financial Flexibility Index for Intech Biopharm Ltd (2017–2025)
Year-by-year free cash flow to debt coverage for Intech Biopharm Ltd. Explore Intech Biopharm Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.24x | NT$-297.12 Million | NT$-361.13 Million | NT$1.25 Billion | ▼ -66.6% |
| 2024 | -0.14x | NT$-225.59 Million | NT$-269.22 Million | NT$1.58 Billion | ▼ -26.6% |
| 2023 | -0.11x | NT$-173.93 Million | NT$-204.13 Million | NT$1.54 Billion | ▲ +4.6% |
| 2022 | -0.12x | NT$-179.39 Million | NT$-190.39 Million | NT$1.52 Billion | ▲ +16.7% |
| 2021 | -0.14x | NT$-179.30 Million | NT$-200.61 Million | NT$1.26 Billion | ▼ -53.8% |
| 2020 | -0.09x | NT$-119.22 Million | NT$-167.38 Million | NT$1.29 Billion | ▲ +30.6% |
| 2019 | -0.13x | NT$-137.79 Million | NT$-189.09 Million | NT$1.04 Billion | ▼ -379.3% |
| 2018 | -0.03x | NT$-28.41 Million | NT$-232.43 Million | NT$1.02 Billion | ▼ -121.8% |
| 2017 | 0.13x | NT$112.97 Million | NT$-145.29 Million | NT$887.48 Million | — |